Survival Following Trimodality Therapy in Patients with Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?

OBJECTIVE: To evaluate whether pathologic complete response (pCR) exclusively defines major pathologic response to treatment with improved survival. SUMMARY BACKGROUND DATA: pCR following trimodality therapy for esophagogastric adenocarcinoma is infrequent but associated with improved prognosis. Yet...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Surg
Autori principali: Sihag, Smita, Nobel, Tamar, Hsu, Meier, De La Torre, Sergio, Tan, Kay See, Janjigian, Yelena Y., Ku, Geoffrey Y., Tang, Laura H., Wu, Abraham J., Maron, Steven B., Bains, Manjit S., Jones, David R., Molena, Daniela
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2022
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8126574/
https://ncbi.nlm.nih.gov/pubmed/33214465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SLA.0000000000004638
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi